HER2+ Metastatic Breast Cancer: Standard of Care Therapies

0 Views
administrator
administrator
07/03/23

Sara A. Hurvitz, MD, FACP, provides an overview of the standard of care for the treatment of HER2+ metastatic breast cancer along with treatment with T-DM1 as seen in the EMILIA trial.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next